Chronic myeloid leukemia patients with the b3/a2 transcript have significantly higher platelet counts at diagnosis.

Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/23899

DC Field	Value	Language
dc.contributor.author	Panovska I	en_US
dc.contributor.author	Georgievski B	en_US
dc.contributor.author	Cevreska L	en_US
dc.contributor.author	Siljanovski N	en_US
dc.contributor.author	Pavkovic M	en_US
dc.contributor.author	Hadzi-Pecova L	en_US
dc.contributor.author	Crcareva A	en_US
dc.contributor.author	Pivkova A	en_US
dc.contributor.author	Efremov DG	en_US
dc.date.accessioned	2022-10-28T08:34:28Z	-
dc.date.available	2022-10-28T08:34:28Z	-
dc.date.issued	2002	-
dc.identifier.uri	http://hdl.handle.net/20.500.12188/23899	-
dc.language.iso	en	en_US
dc.relation.ispartof	Hematology Journal	en_US
dc.title	Chronic myeloid leukemia patients with the b3/a2 transcript have significantly higher platelet counts at diagnosis.	en_US
dc.type	Proceeding article	en_US
dc.relation.conference	7th Meeting of the European Hematology Association, Florence, Italy, 6-9 June 2002.	en_US
item.grantfulltext	open	-
item.fulltext	With Fulltext	-
crisitem.author.dept	Faculty of Medicine	-
crisitem.author.dept	Faculty of Medicine	-
crisitem.author.dept	Faculty of Medicine	-
crisitem.author.dept	Faculty of Medicine	-
crisitem.author.dept	Faculty of Medicine	-
Appears in Collections:	Faculty of Medicine: Conference papers